Delivery Order SPE2DR25D3102-SPE2DR26F2P9P
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription pharmaceutical product used in treating autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,154.12 and is scheduled for completion by December 31, 2025. The contract was awarded competitively with no set-aside designation, and performance will be executed from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mL, a biological pharmaceutical used to treat autoimmune conditions. The contract is valued at $9,065.07 with a firm fixed price structure and an ultimate completion date of December 15, 2025. This is a non-set-aside award, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,989.95 on December 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune diseases. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,326.19 on October 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, non-set-aside contract has a ceiling value of $67,903.44 with firm fixed pricing and is scheduled for completion by December 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $1,210.98 and is scheduled for completion by November 21, 2025. The contract represents a non-set-aside award, indicating it was competitively awarded to AmerisourceBergen based on its demonstrated capability to meet...
- The Defense Logistics Agency awarded a $13,857.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product for treating autoimmune conditions. This non-set-aside competitive award is scheduled for completion by December 5, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,328.55 and is scheduled for completion by December 31, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat autoimmune conditions. The contract is a firm fixed-price delivery order with a ceiling value of $1,193.97 and an ultimate completion date of November 25, 2025. This award is non-set-aside and represents a competitive procurement action. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $12,360.33 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 8, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under...